Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

01. Mai 2026 06:46 ET | Quelle: Bleichmar Fonti & Auld

Investor Notice: Medpace (NASDAQ:MEDP) may have Committed Securities Fraud after Cancellation Rates Disclosed – Contact BFA Law about the Pending Class Action

Medpace (NASDAQ:MEDP) may have Committed Securities Fraud after Cancellation Rates Disclosed – Contact BFA Law about the Pending Class Action
29. April 2026 06:36 ET | Quelle: Bleichmar Fonti & Auld

$MEDP Fraud: Medpace Cancellation Rates Trigger Securities Class Action – Investors Alerted to Contact BFA Law

Medpace Cancellation Rates Trigger Securities Class Action – Investors Alerted to Contact BFA Law
27. April 2026 06:11 ET | Quelle: Bleichmar Fonti & Auld

Court Reminder: Medpace (NASDAQ:MEDP) June 8 Legal Deadline in Securities Class Action is Approaching – Investors with Losses Urged to Contact BFA Law

Medpace (NASDAQ:MEDP) June 8 Legal Deadline in Securities Class Action is Approaching – Investors with Losses Urged to Contact BFA Law
23. April 2026 12:12 ET | Quelle: Robbins Geller Rudman & Dowd LLP

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Medpace Holdings Inc. (MEDP) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

The case alleges Medpace oversold its projected book-to-bill ratio for fourth quarter 2025.
17. April 2026 09:33 ET | Quelle: Robbins Geller Rudman & Dowd LLP

MEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

The case alleges Medpace oversold its projected book-to-bill ratio for fourth quarter 2025.
13. April 2026 05:59 ET | Quelle: Robbins Geller Rudman & Dowd LLP

MEDP INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Action Lawsuit

The case alleges Medpace oversold its projected book-to-bill ratio for fourth quarter 2025.
07. April 2026 18:50 ET | Quelle: Robbins Geller Rudman & Dowd LLP

MEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Medpace Class Action Lawsuit – RGRD Law

The case alleges Medpace oversold its projected book-to-bill ratio for fourth quarter 2025.